Shandong Weigao Group Medical Polymer's (HKG:1066) affiliate Weigao Blood Purification Products completed the acquisition of Shandong WEGO Prefills Pharmaceutical Packaging, according to a Friday filing with the Hong Kong bourse.

The buyer issued an adjusted 277 million shares to the target's shareholders, Weihai Shengxi Enterprise Management Consulting Center, and Weihai Ruiming Enterprise Management Consulting Partnership, to settle the purchase.

Following completion, the group, including the company and Weihai Ruiming, will hold 364.2 million, or 52.42%, shares in Weigao Blood Purification, which will become a unit of the company.

The parties had entered into a letter of intent for the acquisition in October 2025.